Summary Institute for Molecular Medicine Finland (FIMM) is a research institute that conducts research activities in the fields of human genomics and personalized medicine.The institute develops diagnostics, treatment and prevention of common health problems using Finnish clinical and epidemiological study materials.
It offers services such as cell line authentication, capillary sequencing, SNP genotyping and CNV analysis, gene expression analysis, assay development and screening format adaptation, secondary assay testing and microarray printing, among others.FIMM’s technology centre offers bioinformatics, digital microscopy and molecular pathology, extracellular vesicles, genotyping, high content imaging and analysis, high throughput biomedicine (htb), IT, metabolomics, sequencing and single cell analytics, among others.
The institute provides doctoral training, FIMMPOD Postdoctoral program and other activities. FIMM is headquartered in Helsinki, Finland.
Institute for Molecular Medicine Finland - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings.The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period.
The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope - Financial Deals - Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. - Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. - Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. - Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. - Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector. - Major Deals - Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios. - Business Description - A brief description of the company’s operations. - Key Employees - A list of the key executives of the company. - Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company. - Key Competitors - A list of the key competitors of the company. - Key Recent Developments - A brief on recent news about the company.
Reasons to Buy Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements - The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy - The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Our reports have been used by over 10K customers, including:
112 pages •
By Global Industry Analysts
• Feb 2020
Genotyping market worldwide is projected to grow by US$31 Billion, driven by a compounded growth of 20.6%. Polymerase Chain Reaction (PCR), one of the segments analyzed and sized in this study, displays the potential to grow at over 20.4%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast...
Market Overview The major factors, such as increasing applications of NGS, speed, cost, and accuracy, efficient replacement for traditional technologies, and drug discovery applications demanding NGS technology are expected to drive the growth of the overall market. The rapid speed, cost, and accuracy of the NGS...
The global NGS market is projected to grow at a CAGR of 20.9% during the forecast period. The next-generation sequencing (NGS) market is projected to reach USD 24.4 billion by 2025 from USD 7.8 billion in 2019, at a CAGR of 20.9%. The growth of this market is largely driven by advancements in and the declining costs of...
Hepatitis Test Kits - Medical Devices Pipeline Assessment, 2019 Summary Medical Devices sector report, “Hepatitis Test Kits - Medical Devices Pipeline Assessment, 2019" provides an overview of Hepatitis Test Kits currently in pipeline stage. The report provides comprehensive information on...
Market Overview Cancer rates could further increase by 50%, to 15 million new cases, by 2020, as per the World Cancer Report. It also provides clear evidence that healthy lifestyles and public health action by governments and health practitioners can prevent as many as one-third of cancers, worldwide. The American Cancer...
102 pages •
By Global Industry Analysts
• Feb 2020
Microbiome Sequencing Services market worldwide is projected to grow by US$1.8 Billion, driven by a compounded growth of 18.6%. Synthesis, one of the segments analyzed and sized in this study, displays the potential to grow at over 17.5%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast...
101 pages •
By Global Industry Analysts
• Feb 2020
Metabolomics market worldwide is projected to grow by US$1.9 Trillion, driven by a compounded growth of 13.6%. Bioanalytical Instruments & Equipment, one of the segments analyzed and sized in this study, displays the potential to grow at over 11.9%. The shifting dynamics supporting this growth makes it critical for businesses in this space...
This 180-page report provides detailed analyses of current and emerging molecular diagnostic technologies, and their potential market applications, including DNA sequencing, RNA probes, detection technologies, biochips, genosensors, microarrays, labs-on-the-chip, and other.The report also presents strategic assessments of current...
This report provides a worldwide overview of the molecular diagnostics market, including estimates of facilities performing DNA sequencing and molecular diagnostic testing, as well as test volume and sales forecasts by country. The report also presents strategic profiles of current and emerging suppliers of molecular diagnostic products...
278 pages •
By Roots Analysis Private Ltd.
• Dec 2019
INTRODUCTION Advances in DNA sequencing technologies have led to significant developments in a variety of healthcare-focused research fields, such as precision medicine and diagnostics. Particularly, the impact of next generation sequencing (NGS) methods, enabling whole genome and whole exome sequencing, has been the most...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.